stoxline Quote Chart Rank Option Currency Glossary
Sanofi (SNY)
47.94  -0.6 (-1.24%)    05-28 16:00
Open: 48.43
High: 48.47
Volume: 1,336,227
Pre. Close: 48.54
Low: 47.8
Market Cap: 120,129(M)
Technical analysis
2024-05-28 4:56:07 PM
Short term     
Mid term     
Targets 6-month :  57.17 1-year :  59.07
Resists First :  48.94 Second :  50.58
Pivot price 49.13
Supports First :  46.31 Second :  38.52
MAs MA(5) :  48.95 MA(20) :  49.2
MA(100) :  48.54 MA(250) :  50.16
MACD MACD :  0.1 Signal :  0.2
%K %D K(14,3) :  19.6 D(3) :  41
RSI RSI(14): 45.1
52-week High :  55.72 Low :  42.63
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ SNY ] has closed above bottom band by 5.6%. Bollinger Bands are 28.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 48.57 - 48.87 48.87 - 49.08
Low: 47.1 - 47.49 47.49 - 47.78
Close: 47.43 - 48 48 - 48.43
Company Description

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Headline News

Tue, 28 May 2024
Sanofi Strikes Deal with Novavax on COVID-19 Vaccine - - TipRanks

Mon, 27 May 2024
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag - Zacks Investment Research

Mon, 27 May 2024
Sanofi Diabetes Combination Drug FDA Action Date Extended - Yahoo Singapore News

Mon, 27 May 2024
Sanofi's Sarclisa gets accepted for FDA priority review for treatment of multiple myeloma - Seeking Alpha

Sun, 26 May 2024
Sanofi (SNY) Moves 6.0% Higher: Will This Strength Last? - Yahoo Movies UK

Sun, 26 May 2024
Sanofi (NASDAQ:SNY) Shares Purchased by UBS Group AG - Defense World

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Drug Manufacturers - General
Shares Out 2,500 (M)
Shares Float 1,100 (M)
Held by Insiders 0 (%)
Held by Institutions 10.2 (%)
Shares Short 3,240 (K)
Shares Short P.Month 3,900 (K)
Stock Financials
EPS 1.94
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 59.16
Profit Margin 9.8 %
Operating Margin 18.2 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 2.2 %
Gross Profit (p.s.) 0
Sales Per Share 18.51
EBITDA (p.s.) 4.88
Qtrly Earnings Growth -43.3 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 24.71
PEG Ratio 1.2
Price to Book value 0.81
Price to Sales 2.58
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android